S&P 500   3,384.01 (+0.41%)
DOW   29,322.84 (+0.31%)
QQQ   236.54 (+0.77%)
AAPL   322.32 (+1.04%)
FB   217.48 (-0.15%)
MSFT   187.23 (+0.00%)
GOOGL   1,522.78 (+0.22%)
AMZN   2,171.12 (+0.72%)
CGC   22.11 (+0.77%)
NVDA   309.20 (+4.26%)
BABA   223.18 (+1.21%)
MU   59.11 (+2.36%)
GE   12.82 (+0.55%)
TSLA   914.58 (+6.54%)
AMD   58.23 (+2.36%)
T   38.30 (+0.10%)
ACB   1.70 (+3.66%)
F   8.08 (+0.25%)
NFLX   389.00 (+0.31%)
PRI   136.41 (+0.58%)
BAC   34.54 (+0.76%)
DIS   140.50 (+0.98%)
GILD   66.95 (-0.09%)
S&P 500   3,384.01 (+0.41%)
DOW   29,322.84 (+0.31%)
QQQ   236.54 (+0.77%)
AAPL   322.32 (+1.04%)
FB   217.48 (-0.15%)
MSFT   187.23 (+0.00%)
GOOGL   1,522.78 (+0.22%)
AMZN   2,171.12 (+0.72%)
CGC   22.11 (+0.77%)
NVDA   309.20 (+4.26%)
BABA   223.18 (+1.21%)
MU   59.11 (+2.36%)
GE   12.82 (+0.55%)
TSLA   914.58 (+6.54%)
AMD   58.23 (+2.36%)
T   38.30 (+0.10%)
ACB   1.70 (+3.66%)
F   8.08 (+0.25%)
NFLX   389.00 (+0.31%)
PRI   136.41 (+0.58%)
BAC   34.54 (+0.76%)
DIS   140.50 (+0.98%)
GILD   66.95 (-0.09%)
S&P 500   3,384.01 (+0.41%)
DOW   29,322.84 (+0.31%)
QQQ   236.54 (+0.77%)
AAPL   322.32 (+1.04%)
FB   217.48 (-0.15%)
MSFT   187.23 (+0.00%)
GOOGL   1,522.78 (+0.22%)
AMZN   2,171.12 (+0.72%)
CGC   22.11 (+0.77%)
NVDA   309.20 (+4.26%)
BABA   223.18 (+1.21%)
MU   59.11 (+2.36%)
GE   12.82 (+0.55%)
TSLA   914.58 (+6.54%)
AMD   58.23 (+2.36%)
T   38.30 (+0.10%)
ACB   1.70 (+3.66%)
F   8.08 (+0.25%)
NFLX   389.00 (+0.31%)
PRI   136.41 (+0.58%)
BAC   34.54 (+0.76%)
DIS   140.50 (+0.98%)
GILD   66.95 (-0.09%)
S&P 500   3,384.01 (+0.41%)
DOW   29,322.84 (+0.31%)
QQQ   236.54 (+0.77%)
AAPL   322.32 (+1.04%)
FB   217.48 (-0.15%)
MSFT   187.23 (+0.00%)
GOOGL   1,522.78 (+0.22%)
AMZN   2,171.12 (+0.72%)
CGC   22.11 (+0.77%)
NVDA   309.20 (+4.26%)
BABA   223.18 (+1.21%)
MU   59.11 (+2.36%)
GE   12.82 (+0.55%)
TSLA   914.58 (+6.54%)
AMD   58.23 (+2.36%)
T   38.30 (+0.10%)
ACB   1.70 (+3.66%)
F   8.08 (+0.25%)
NFLX   389.00 (+0.31%)
PRI   136.41 (+0.58%)
BAC   34.54 (+0.76%)
DIS   140.50 (+0.98%)
GILD   66.95 (-0.09%)
Log in

NYSE:CLB - Core Laboratories Stock Price, Forecast & News

$33.01
-0.02 (-0.06 %)
(As of 02/19/2020 09:41 AM ET)
Today's Range
$32.77
Now: $33.01
$33.26
50-Day Range
$33.03
MA: $37.43
$41.24
52-Week Range
$32.54
Now: $33.01
$75.63
Volume6,600 shs
Average Volume676,684 shs
Market Capitalization$1.47 billion
P/E Ratio14.48
Dividend Yield2.96%
Beta1.84
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. Read More…

Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
CUSIPN/A
Phone31-20-420-3191

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$668.21 million
Cash Flow$2.26 per share
Book Value$4.10 per share

Profitability

Net Income$101.98 million

Miscellaneous

Employees4,300
Market Cap$1.47 billion
Next Earnings Date4/22/2020 (Estimated)
OptionableOptionable

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.


Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Wednesday, January 15th. Investors of record on Friday, January 24th will be paid a dividend of $0.25 per share on Friday, February 14th. This represents a $1.00 dividend on an annualized basis and a yield of 3.03%. The ex-dividend date of this dividend is Thursday, January 23rd. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) announced its quarterly earnings results on Wednesday, January, 29th. The oil and gas company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.37 by $0.01. The oil and gas company had revenue of $157 million for the quarter, compared to the consensus estimate of $155.31 million. Core Laboratories had a net margin of 15.26% and a return on equity of 42.25%. The business's revenue was down 9.4% on a year-over-year basis. During the same period last year, the firm earned $0.48 earnings per share. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, April 22nd 2020. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its first quarter earnings guidance on Wednesday, January, 29th. The company provided earnings per share (EPS) guidance of $0.39-0.41 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.39. The company issued revenue guidance of $159-164 million, compared to the consensus revenue estimate of $159.64 million.

What price target have analysts set for CLB?

13 Wall Street analysts have issued twelve-month price objectives for Core Laboratories' shares. Their forecasts range from $36.00 to $77.00. On average, they anticipate Core Laboratories' stock price to reach $47.86 in the next year. This suggests a possible upside of 45.0% from the stock's current price. View Analyst Price Targets for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Has Core Laboratories been receiving favorable news coverage?

News coverage about CLB stock has trended very positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Core Laboratories earned a media sentiment score of 3.5 on InfoTrie's scale. They also assigned media stories about the oil and gas company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Core Laboratories.

Are investors shorting Core Laboratories?

Core Laboratories saw a increase in short interest in January. As of January 31st, there was short interest totalling 3,660,000 shares, an increase of 29.3% from the January 15th total of 2,830,000 shares. Based on an average trading volume of 696,500 shares, the days-to-cover ratio is presently 5.3 days. Currently, 8.4% of the company's stock are short sold. View Core Laboratories' Current Options Chain.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Starbucks (SBUX), Micron Technology (MU), AT&T (T), Baidu (BIDU), NIC (EGOV) and Netflix (NFLX).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
  • Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (10.70%), Earnest Partners LLC (6.61%), Van ECK Associates Corp (5.67%), Kayne Anderson Rudnick Investment Management LLC (3.45%), Mairs & Power INC (2.28%) and Bank of New York Mellon Corp (1.74%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View Institutional Ownership Trends for Core Laboratories.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, Baird Financial Group Inc., Manning & Napier Group LLC, Kayne Anderson Rudnick Investment Management LLC, Eaton Vance Management, Schroder Investment Management Group, Penn Capital Management Co. Inc. and Evercore Wealth Management LLC. Company insiders that have sold Core Laboratories company stock in the last year include Kevin Daniels and Mark F Elvig. View Insider Buying and Selling for Core Laboratories.

Which major investors are buying Core Laboratories stock?

CLB stock was bought by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, C Partners Holding GmbH, Thrivent Financial for Lutherans, Mairs & Power INC, Teacher Retirement System of Texas, Douglas Lane & Associates LLC, Bank of Montreal Can and Earnest Partners LLC. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland and Lawrence Bruno. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $33.01.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $1.47 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.View Additional Information About Core Laboratories.

What is Core Laboratories' official website?

The official website for Core Laboratories is http://www.corelab.com/.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]


MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  453 (Vote Outperform)
Underperform Votes:  599 (Vote Underperform)
Total Votes:  1,052
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel